We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$536M
Cap. Flow %
9.53%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 34.82%
2 Healthcare 28.77%
3 Real Estate 5.15%
4 Financials 4.39%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PANW icon
226
Palo Alto Networks
PANW
$293B
$1.99M 0.04%
+17,000
New +$2.01M
FRBN
227
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
$1.99M 0.04%
181,263
– –
WEL
228
DELISTED
Integrated Wellness Acquisition Corp
WEL
$1.99M 0.04%
181,263
– –
CSCO icon
229
Cisco
CSCO
$476B
$1.96M 0.03%
+36,506
New +$1.97M
MTCH icon
230
Match Group
MTCH
$8.4B
$1.96M 0.03%
50,000
+25,000
+100% +$1.11M
ESTA icon
231
Establishment Labs
ESTA
$2.33B
$1.96M 0.03%
39,902
+3,000
+8% +$179K
DCPH
232
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.96M 0.03%
153,737
+77,000
+100% +$1.06M
MIRM icon
233
Mirum Pharmaceuticals
MIRM
$5.74B
$1.93M 0.03%
61,000
+37,000
+154% +$1.01M
KROS icon
234
Keros Therapeutics
KROS
$211M
$1.92M 0.03%
60,341
+5,000
+9% +$187K
ROIV icon
235
Roivant Sciences
ROIV
$25.4B
$1.92M 0.03%
164,211
-26,000
-14% -$294K
TAL icon
236
TAL Education Group
TAL
$6.91B
$1.92M 0.03%
+210,317
New +$1.47M
MTZ icon
237
MasTec
MTZ
$20.8B
$1.89M 0.03%
26,295
+4,300
+20% +$429K
TEVA icon
238
Teva Pharmaceuticals
TEVA
$40.6B
$1.89M 0.03%
+185,000
New +$1.72M
NFYS
239
DELISTED
Enphys Acquisition Corp.
NFYS
$1.87M 0.03%
178,033
– –
HOLI
240
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$1.86M 0.03%
+93,570
New +$1.69M
KNSA icon
241
Kiniksa Pharmaceuticals
KNSA
$5.97B
$1.85M 0.03%
106,423
-115,000
-52% -$1.94M
MGM icon
242
MGM Resorts International
MGM
$11.2B
$1.82M 0.03%
49,500
-359,902
-88% -$15.9M
KIDS icon
243
OrthoPediatrics
KIDS
$596M
$1.8M 0.03%
56,219
+11,000
+24% +$424K
AXSM icon
244
Axsome Therapeutics
AXSM
$10.8B
$1.8M 0.03%
25,735
– –
RCUS icon
245
Arcus Biosciences
RCUS
$3.61B
$1.78M 0.03%
99,412
-5,000
-5% -$100K
TCOM icon
246
Trip.com Group
TCOM
$29.1B
$1.75M 0.03%
50,000
-7,500
-13% -$282K
BCRX icon
247
BioCryst Pharmaceuticals
BCRX
$2.38B
$1.71M 0.03%
241,820
+9,357
+4% +$67.2K
XFOR icon
248
X4 Pharmaceuticals
XFOR
$393M
$1.7M 0.03%
52,000
+37,000
+247% +$1.61M
PATH icon
249
UiPath
PATH
$7.25B
$1.67M 0.03%
+97,500
New +$1.62M
XENE icon
250
Xenon Pharmaceuticals
XENE
$6.24B
$1.66M 0.03%
48,676
+10,000
+26% +$374K
8 9
10
11 12

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $536M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 16% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.